Wegovy Flextouch 2.4MG Inj

Composition

Semaglutide 2.4 mg/0.75 mL solution for injection (prefilled pen); pen contains 3 mL (total semaglutide 9.6 mg)

Uses of Wegovy Flextouch 2.4MG Inj

Chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity (e.g., hypertension, dyslipidaemia, type 2 diabetes); used along with reduced-calorie diet and increased physical activity.

• •Helps significant weight loss
• •Reduces appetite and cravings
• •Improves waist circumference and cardiometabolic risk factors
• •Once-weekly dosing
• •May improve glycaemic control in patients with type 2 diabetes

How it works

Semaglutide is a GLP-1 receptor agonist that increases satiety and reduces hunger by acting on appetite-regulating centers in the brain. It also slows gastric emptying and can improve glucose control, leading to reduced calorie intake and weight loss.

Directions for use

Subcutaneous injection once weekly on the same day each week, at any time of day, with or without meals. Inject into abdomen, thigh, or upper arm; rotate injection sites. Use only after completing dose escalation and as prescribed; do not share the pen/needles; follow pen instructions for priming and dose delivery.

Side effects

Common side effects of Wegovy Flextouch 2.4MG Inj may include:

• •Nausea
• •vomiting
• •